Holenz jörg (7 Ergebnisse)

Softcover. Zustand: Fine. Leichte Kratzer / Abnutzungen / Druckstellen; Leichte Verformung / umgeknickte Seiten. Een verfijnde soep is het perfecte begin van elk menu, een rijk gevuld eenpansgerecht verwarmt de inwendige mens op koude dagen en een heerlijke stoofschotel valt altijd bij uw gasten in de smaak. En het mooiste van eenpansgerechten, of ze nu in een stoofpan of in een soeppan zijn bereid, is dat ze snel klaar zijn en altijd lukken.…

Gebunden. Zustand: New. Alleyn Plowright, PhD, is Head of Integrated Drug Discovery Germany at Sanofi. He leads a cross-disciplinary research unit driving projects from target validation through to pre-clinical development. He has been instrumental in delivering a number of compou.

Gebunden. Zustand: New. Michael Gruss, owner and founder of Solid State Concepts, works as an independent scientific consultant for the pharmaceutical, chemical and nutrition industry. He earned a PhD in chemistry from Giessen University in 1998. In 2000, he joined Gruenenthal GmbH.

Gebunden. Zustand: New. Norbert Handler holds a PhD in Medicinal Chemistry from the University of Vienna, where he worked for several years as a postdoc scientist in the field of Medicinal Chemistry. He received an Erwin-Schroedinger-Scholarship and moved to ETH Zuerich where he joi.

Zustand: New. Wolfgang Sippl, PhD, holds the chair in Medicinal Chemistry at the Institute of Pharmacy at the Martin Luther University of Halle-Wittenberg. Manfred Jung, PhD, is a full professor for Pharmaceutical Chemistry at the University of Freiburg and the co-chair.

Zustand: New. Helga Ruebsamen-Schaeff, PhD, is founding CEO of AiCuris and the chair of AiCuris Scientific Advisory Board. Before founding AiCuris she served at Bayer as SVP and Head of Infectious Disease Research. Before that time, she was Scientific and Managing Direct.

Zustand: New. Joerg Holenz is a trained organic and medicinal chemist and acquired his PhD in Germany on the synthesis of alkaloids as antimalarial agents. After leading the preclinical activities of the marketed analgesic Tapentadol (Gruenenthal Pharmaceuticals GmbH), he.